Post by
Ogre03 on Dec 02, 2020 11:42am
Concerns sort of short term sort of not
First post long time lurker. So here be the concern / concerns. This r/s happened with no real news nor a share price to be able to uplist on Nyse. Makes me like a smoke and mirror show to buy time. Which leads to a bigger concern of a large offering to raise capital inorder to move the two drugs ahead with out partnership thus driving share price to the celler if of course that happens before news of official phase three confirmation and a 352 phase one start. As well not a huge fan of reverse splits especially at this stage of things.
Comment by
MrMugsy on Dec 02, 2020 11:51am
Welcome Ogre ! I'm not a fan of R/S either - unless there is a gameplan. Thinking we have ourselves a gameplan. Will see. Going to market for more capital ... maybe ... sure hope they don't yet. Going to US market is a potential - a possibility. I'm going to guess it all depends on how/where negotiations are going.
Comment by
Ogre03 on Dec 02, 2020 12:00pm
I do not think Negotiations have really gotten serious yet. Why would they reverse split before news of that nature came out if it was close? Maybe I am just being paranoid about holding this bag I have
Comment by
NotBornLastNite on Dec 02, 2020 12:16pm
My bet is a bag of riches longer term. Watching the markets on a daily basis, or hourly drives me nuts sometimes. Put this one to bed for six months and when it awakens you may be pleasantly surprised. GL
Comment by
Inthepez on Dec 02, 2020 12:18pm
This account belongs to duster the dumpster. Same argument (with a softer tone) but different account. The account was opened today haha.
Comment by
Ogre03 on Dec 02, 2020 1:04pm
better then me. Got burnt trying to play some dips lol. Average is up to .38 or 3.8 depending on how you look at it. The bought deal and that run up in aug 2019 still leaves a sour taste. Maybe I hold a grudge lol
Comment by
MrMugsy on Dec 02, 2020 1:10pm
Ya - maybe. But you won't be holding a grudge at $7, or $8 or $10 etc. The past will be a blur if their first drug is as good as we're thinking. Phase 2 says we're looking good. If FDA welcomes us to Phase 3, we just need an air tight plan to get us through it. That plan is probably built now.
Comment by
Inthepez on Dec 02, 2020 1:37pm
Fair enough. As you can see, the FUD fairy drops in quite frequently. Hope this drug hits the market soon enough, esp for people in your similar situation
Comment by
endpntplay on Dec 02, 2020 12:43pm
Game plan seems pretty clear: operate and dress Antibe up as a real biotech company (complete rebrand, experience added to management team, respectable share float and no longer a penny stock on a small exchange). Next up is selling Citagenix and selling equity to a large pharma partner to fund their PH3 to completion in the US.
Comment by
Ogre03 on Dec 02, 2020 1:01pm
I have been wondering about Citagenix. Can't find it in the web site and in the filings on the 12th a loss was logged from discontinued sales. I'm still pretty new to this stuff but maybe they closed the doors on Citagenix all ready to focus on the H2S platforms.
Comment by
MrMugsy on Dec 02, 2020 1:05pm
No - doors are open. Maybe a deal next year - after COVID - trying for a better valuation, so I hear. Use this URL ... https://www.citagenix.com/
Comment by
Ogre03 on Dec 02, 2020 1:27pm
Cool beans. I have been ignoring the whole Citagenix scenario for the most part. If they do sell hopefully get enough to run 352 phase one. Woot woot.
Comment by
MrMugsy on Dec 02, 2020 1:01pm
I like the way you think endpntplay. Not bad. One piece still in question ... the small matter of Antibe Holdings Inc. That part of the company is still a little messy for a buyer and needs to be cleaned up. Let's see how that plays out.